12 Results for "
polyol pathway
" in MedChemExpress (MCE) Product Catalog:
Products (12)
12 Results for "polyol pathway" in MCE Product Catalog:
2
2 Cited Publications
Cat. No.: HY-50289
CAS No.: 68367-52-2
Target:
Research Areas:
Sorbinil is an aldose reductase inhibitor (ARI) that prevents the accumulation of sorbitol in cells or animals. Sorbinil is useful in studying diabetes and diabetic complications, reducing AR activity and inhibiting the polyol pathway.
1
1 Cited Publications
Cat. No.: HY-N6845
CAS No.: 19275-46-8
Target:
Cat. No.: HY-131542
CAS No.: 100750-39-8
Target:
Research Areas:
APPA is an aldose reductase inhibitor. APPA can effectively prevent apoptosis and the symptoms of Streptozotocin (HY-13753)-induced diabetes by inhibiting the polyol pathway in rats. APPA has the potential for diabetic nephropathy (DN) research .
Cat. No.: HY-50289R
CAS No.: 68367-52-2
Target:
Research Areas:
Sorbinil (Standard) is the analytical standard of Sorbinil. This product is intended for research and analytical applications. Sorbinil is an aldose reductase inhibitor (ARI) that prevents the accumulation of sorbitol in cells or animals. Sorbinil is useful in studying diabetes and diabetic complications, reducing AR activity and inhibiting the polyol pathway .
Cat. No.: HY-W768347
Synonyms: Xylite-13C5
Cat. No.: HY-187119
CAS No.: 158575-73-6
Target:
Research Areas:
CC13401 is an aldose reductase (ALR2) inhibitor with an IC50 of 41.41 μM in rats. CC13401 inhibits the NADPH-dependent reduction reaction catalyzed by ALR2. CC13401 can be used in studies on the mechanisms related to the polyol pathway and diabetic complications .
Cat. No.: HY-119058
CAS No.: 463976-07-0
Synonyms: CP-744809
Target:
Research Areas:
ARI-809 (CP-744809) is a highly selective, orally active aldose reductase inhibitor with an IC50 of 1 nM. ARI-809 blocks excessive glucose flux through the polyol pathway. ARI-809 normalizes elevated sorbitol and fructose levels in sciatic nerve tissues of diabetic rat models, inhibits sorbitol accumulation in lens tissues, and brings elevated urinary albumin excretion close to normal. ARI-809 can be used in diabetes research .
Cat. No.: HY-184330
Target:
Research Areas:
ALR2/α-Glucosidase-IN-2 is an inhibitor of α-glucosidase and aldose reductase ALR2. ALR2/α-Glucosidase-IN-2 has a Ki value of 11.68 nM against yeast α-glucosidase and a Ki value of 72.64 nM against ovine ALR2. ALR2/α-Glucosidase-IN-2 inhibits intestinal carbohydrate digestion regulatory enzymes and key enzymes in the polyol pathway. ALR2/α-Glucosidase-IN-2 can be used in diabetes-related research .
Cat. No.: HY-189722
Research Areas:
Multi-target kinase-IN-13 is a multi-target enzyme inhibitor and antioxidant. Multi-target kinase-IN-13 inhibits α-amylase, α-glucosidase, and aldose reductase, with IC50 values of 6.71, 4.78, and 4.04 µg/mL, respectively, thereby slowing starch digestion, reducing intestinal glucose absorption, and inhibiting the polyol pathway. Multi-target kinase-IN-13 scavenges DPPH, ABTS, and NO free radicals and exhibits antioxidant capacity and ferric reducing ability. Multi-target kinase-IN-13 can be used in studies related to diabetes and antioxidation .
Cat. No.: HY-184036
CAS No.: 56759-56-9